Edwin Mak

5.0k total citations
53 papers, 3.6k citations indexed

About

Edwin Mak is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Edwin Mak has authored 53 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Neurology, 19 papers in Cellular and Molecular Neuroscience and 7 papers in Cognitive Neuroscience. Recurrent topics in Edwin Mak's work include Parkinson's Disease Mechanisms and Treatments (35 papers), Neurological disorders and treatments (34 papers) and Botulinum Toxin and Related Neurological Disorders (10 papers). Edwin Mak is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (35 papers), Neurological disorders and treatments (34 papers) and Botulinum Toxin and Related Neurological Disorders (10 papers). Edwin Mak collaborates with scholars based in Canada, United States and Australia. Edwin Mak's co-authors include Michael Schulzer, Donald B. Calne, A. Jon Stoessl, Raúl de la Fuente‐Fernández, Vesna Sossi, Thomas J. Ruth, Joseph Tsui, C. S. Lee, Ramachandiran Nandhagopal and B. J. Snow and has published in prestigious journals such as The Lancet, JAMA and PLoS ONE.

In The Last Decade

Edwin Mak

53 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin Mak Canada 33 2.5k 1.1k 556 468 350 53 3.6k
Joseph Ghika Switzerland 36 2.4k 1.0× 1.1k 1.0× 721 1.3× 270 0.6× 630 1.8× 88 3.8k
Peter Kempster Australia 27 3.0k 1.2× 772 0.7× 388 0.7× 440 0.9× 326 0.9× 87 3.8k
Petr Kaňovský Czechia 35 2.8k 1.1× 801 0.7× 382 0.7× 458 1.0× 474 1.4× 232 4.0k
G. Arnold Germany 31 1.6k 0.6× 720 0.6× 258 0.5× 388 0.8× 300 0.9× 76 2.8k
Carsten Buhmann Germany 32 2.2k 0.9× 889 0.8× 505 0.9× 512 1.1× 524 1.5× 146 3.7k
Paolo Martinelli Italy 33 2.4k 1.0× 928 0.8× 503 0.9× 342 0.7× 327 0.9× 118 3.6k
Daniel R. Kramer United States 16 1.5k 0.6× 996 0.9× 745 1.3× 243 0.5× 324 0.9× 61 3.2k
Abraham Lieberman United States 34 2.3k 0.9× 973 0.9× 881 1.6× 306 0.7× 257 0.7× 157 4.3k
Jose‐Alberto Palma United States 31 1.6k 0.7× 638 0.6× 322 0.6× 529 1.1× 357 1.0× 120 3.0k
Claire Thalamas France 34 1.7k 0.7× 679 0.6× 494 0.9× 860 1.8× 560 1.6× 94 4.3k

Countries citing papers authored by Edwin Mak

Since Specialization
Citations

This map shows the geographic impact of Edwin Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin Mak more than expected).

Fields of papers citing papers by Edwin Mak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin Mak. The network helps show where Edwin Mak may publish in the future.

Co-authorship network of co-authors of Edwin Mak

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin Mak. A scholar is included among the top collaborators of Edwin Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin Mak. Edwin Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sossi, Vesna, Katherine Dinelle, Michael Schulzer, et al.. (2010). Levodopa and pramipexole effects on presynaptic dopamine PET markers and estimated dopamine release. European Journal of Nuclear Medicine and Molecular Imaging. 37(12). 2364–2370. 30 indexed citations
2.
Fuente‐Fernández, Raúl de la, Michael Schulzer, Edwin Mak, & Vesna Sossi. (2010). Trials of neuroprotective therapies for Parkinson’s disease: Problems and limitations. Parkinsonism & Related Disorders. 16(6). 365–369. 32 indexed citations
3.
Purssell, Roy, Douglas Brown, Jeffrey R. Brubacher, et al.. (2010). Proportion of Injured Drivers Presenting to a Tertiary Care Emergency Department Who Engage in Future Impaired Driving Activities. Traffic Injury Prevention. 11(1). 35–42. 11 indexed citations
4.
Nandhagopal, Ramachandiran, André R. Troiano, Edwin Mak, et al.. (2010). Response to Heat Pain Stimulation in Idiopathic Parkinson's Disease. Pain Medicine. 11(6). 834–840. 31 indexed citations
5.
Troiano, André R., Michael Schulzer, Raúl de la Fuente‐Fernández, et al.. (2009). Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function. Synapse. 64(2). 146–151. 42 indexed citations
6.
Troiano, André R., Raúl de la Fuente‐Fernández, Vesna Sossi, et al.. (2008). PET demonstrates reduced dopamine transporter expression in PD with dyskinesias. Neurology. 72(14). 1211–1216. 82 indexed citations
7.
8.
Kumar, Ajit, Susan Calne, Michael Schulzer, et al.. (2004). Clustering of Parkinson Disease. Archives of Neurology. 61(7). 1057–60. 23 indexed citations
9.
Lee, Chong S., Michael Schulzer, Raúl de la Fuente‐Fernández, et al.. (2004). Lack of Regional Selectivity During the Progression of Parkinson Disease. Archives of Neurology. 61(12). 1920–5. 43 indexed citations
10.
Carr, Jonathan, Raúl de la Fuente‐Fernández, Michael Schulzer, et al.. (2003). Familial and sporadic Parkinson's disease usually display the same clinical features. Parkinsonism & Related Disorders. 9(4). 201–204. 15 indexed citations
11.
Schulzer, Michael, Edwin Mak, & Susan Calne. (2003). The psychometric properties of the Parkinson's Impact Scale (PIMS) as a measure of quality of life in Parkinson's disease. Parkinsonism & Related Disorders. 9(5). 291–294. 18 indexed citations
12.
Fuente‐Fernández, Raúl de la, Pramod Pal, François Vingerhoets, et al.. (2000). Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations. Journal of Neural Transmission. 107(1). 49–57. 55 indexed citations
13.
Wang, Yue, Grace Chan, James E. Holden, et al.. (1998). Age-dependent decline of dopamine D1 receptors in human brain: A PET study. Synapse. 30(1). 56–61. 190 indexed citations
14.
Uitti, Ryan J., et al.. (1997). “Familial Parkinson's Disease” – A Case-Control Study of Families. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 24(2). 127–132. 32 indexed citations
15.
Calne, Susan, Michael Schulzer, Edwin Mak, et al.. (1996). Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS). Parkinsonism & Related Disorders. 2(2). 55–61. 65 indexed citations
16.
Lee, C. S., Michael Schulzer, Edwin Mak, et al.. (1995). Patterns of Asymmetry Do Not Change Over the Course of Idiopathic Parkinsonism. Neurology. 45(3). 435–439. 93 indexed citations
17.
Hammerstad, John P., Katherine Elliott, Edwin Mak, et al.. (1994). Tendon jerks in Parkinson's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 8(1-2). 123–130. 7 indexed citations
18.
Eisen, Andrew, et al.. (1993). Duration of amyotrophic lateral sclerosis is age dependent. Muscle & Nerve. 16(1). 27–32. 99 indexed citations
19.
20.
Teräväinen, H., Joseph Tsui, Edwin Mak, & Donald B. Calne. (1989). Optimal Indices for Testing Parkinsonian Rigidity. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 16(2). 180–183. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Ghika Breakdown of academic impact, for papers by Peter Kempster Breakdown of academic impact, for papers by Petr Kaňovský Breakdown of academic impact, for papers by G. Arnold Breakdown of academic impact, for papers by Carsten Buhmann Breakdown of academic impact, for papers by Paolo Martinelli Breakdown of academic impact, for papers by Daniel R. Kramer Breakdown of academic impact, for papers by Abraham Lieberman Breakdown of academic impact, for papers by Jose‐Alberto Palma Breakdown of academic impact, for papers by Claire Thalamas
Rankless by CCL
2026